Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006576

Chief Financial Officer sold 100,000 shares at an average $56.13 ($5,612,601)

  • Chief Financial Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-01-28 Option exercise +50,000 $6.32 $316,000 51,000 D
Cohen Chad M Chief Financial Officer 2021-01-28 Sale −7,779 $55.04 $428,156 43,221 D
Cohen Chad M Chief Financial Officer 2021-01-28 Sale −23,698 $56.00 $1,327,088 19,523 D
Cohen Chad M Chief Financial Officer 2021-01-28 Sale −18,523 $57.00 $1,055,811 1,000 D
Cohen Chad M Chief Financial Officer 2021-01-29 Option exercise +50,000 $6.32 $316,000 51,000 D
Cohen Chad M Chief Financial Officer 2021-01-29 Sale −38,112 $55.77 $2,125,506 12,888 D
Cohen Chad M Chief Financial Officer 2021-01-29 Sale −9,704 $56.68 $550,023 3,184 D
Cohen Chad M Chief Financial Officer 2021-01-29 Sale −2,184 $57.70 $126,017 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2021-01-28 Option exercise · Stock Option (Right to Buy) −50,000 115,000 D
Cohen Chad M Chief Financial Officer 2021-01-29 Option exercise · Stock Option (Right to Buy) −50,000 65,000 D
Open-market sales · 100,000 sh · avg $56.13 · $5,612,601
Loading xslF345X03/doc4.xml…